Thermo Fisher Scientific (TMO) Is Benefiting From More Than Healthcare Demand: Here’s the Overlooked AI Connection
Thermo Fisher Scientific (TMO) Is Benefiting From More Than Healthcare Demand: Here’s the Overlooked AI Connection Yahoo Finance
Covered in this story
What has happened since
- Thermo Fisher Scientific is down 2.1% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Thermo Fisher Scientific
- Argus Research: at $697 · target $780 by Oct 2027 via GuruFocus
- Citi: at $674 · target $800 by Oct 2027 via GuruFocus
- TD Cowen: at $677 · target $810 by Oct 2027 via GuruFocus
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $TMO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Thermo Fisher Scientific →Dalsna Finance is currently tracking 44 stories mentioning Thermo Fisher Scientific, the earliest published 4 May 2017.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.